The abortion cartel has reacted to a new genre of pro-life laws, which force abortion clinics to administer RU-486 per FDA protocol, in a way that makes no sense.

Four states – Arizona, North Dakota, Ohio, and Oklahoma – have now passed a version of this law, and the abortion lobby has responded by taking the more difficult path - suing to block the statute.

In terms of PR, this is an uphill battle. Abortion proponents are trying to justify giving RU-486 off-label by framing the FDA as incompetent. Quoting Tulsa World, October 1:

The law intrudes on women’s reproductive rights because it forbids the safer, more effective drug process used to end a pregnancy, the lawsuit claims….

“House Bill 2684… requires physicians to ignore decades of medical research, the opinion of leading medical organizations, and their own clinical experience, and instead administer medication abortion according to an outdated and inferior” regime, the lawsuit says.

If all this is true, it would seem smart for the abortion lobby to press the FDA to update its protocol, not only because it is supposedly dangerous as it stands, but also because doing so would pull the plug on an increasingly popular piece of pro-life legislation that hinges entirely on the FDA’s current protocol.

Such an effort would make abortion groups look like leaders in the field of research for advancing abortion safety. It would also save them hundreds of thousands of dollars in legal expenses.

Abortion groups are certainly up to such as task. We now know they goaded the FDA into legalizing RU-486 in the first place. They also successfully applied pressure when wanting Plan B legalized, and then when wanting to make it available over-the-counter.

So why, particularly with an abortion-friendly president puppet master, aren’t abortion groups pressuring the FDA to update its 14-year-old protocol on the dosage, routes of administration, and gestational limits of RU-486?

Here are three of the most likely reasons.

Lying about safety of RU-486 off-label?

The most obvious answer is the abortion industry is lying. As Americans United for Life attorney Mailee Smith noted, eight women are known to have died after using RU-486 per off-label abortion clinic protocol (including 18-year-old Holly Patterson, pictured below left, following a chemical abortion at a California Planned Parenthood in 2003), but no women are known to have died using FDA protocol (which is not to say that’s safe either).

So platitudes are preferable to cold, hard statistics, especially against the prospect of comparing complications.

In Ohio, for instance, there were 42 reports of complications from off-label RU-486 abortions during an 18-month period between 2011-13, 35 of which required a follow-up surgical abortion.

The reality is the abortion industry wants to follow off-label protocol to save on drug expenses, abortionist expenses, and overhead – in other words, to increase its profit margin.

Implications the abortion lobby can’t tolerate?

Laws regulating RU-486 open a new legal door: legislating against abortion at the earliest stages of pregnancy.

“This is a significant place legally for state government to be,” explained Ovide Lamontagne, General Counsel for AUL, in an email. The abortion lobby knows this as dangerous precedent and may think it has no choice but to try to beat it back in court.

[tweet_box]RU-486 laws open a new legal door – regulating abortion at the earliest stages of pregnancy.[/tweet_box]

Chinese manufacturer of RU-486 says screw that?

In this scenario the abortion industry is hoist by its own petard. Since no American pharmaceutical company would touch the manufacture of RU-486, the dirty work was punted to Shanghai New Hualian Pharmaceuticals in China.

Shanghai New Hualian is not known for its concern for humanity. In 2008, the company was caught selling tainted drugs that left “nearly 200 Chinese cancer patients… paralyzed or otherwise harmed,” according to the New York Times.

While Shanghai New Hualian’s RU-486 plant was not implicated in the scandal, the point is corporate likely has zero interest in taking on the expense of conducting new clinical trials for the purported well-being of American abortion patients - particularly to make less money, since the abortion industry advocates using 1/3 the currently recommended dosage. As the proverb goes, “Do not wake sleeping dogs.”

Furthermore, the abortion industry likely has zero interest in showing its “evidence” on the safety of off-label chemical abortions. A “study” it published last year had more holes in it than Swiss cheese.

[tweet_box]The Chinese manufacturer of RU-486 was once busted for selling tainted drugs that killed 200 people.[/tweet_box]

As I wrote yesterday, RU-486 regulation laws stand a great chance of getting the U.S. Supreme Court’s attention, which bodes well for our side.

If SCOTUS confirms states have a right to regulate RU-486 according to FDA protocol, this would really hurt the abortion trade, particularly Planned Parenthood, which runs 90% of RU-486 clinics, and help save babies.